Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 14/20 | 0.43 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | MMP14 | P50281 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1157279 | 0.83 | FDPS (0.48) | FDPSBTN3A1LMNAGGPS1CA12 | |
| SCHEMBL1076063 | 0.80 | FDPS (0.50) | FDPSBTN3A1LMNAGGPS1CA12 | |
| SCHEMBL1028191 | 0.73 | FDPS (0.51) | FDPSBTN3A1LMNAGGPS1CA12 | |
| SCHEMBL1028197 | 0.72 | FDPS (0.58) | FDPSBTN3A1LMNAGGPS1CA12 | |
| SCHEMBL2529194 | 0.72 | CYP11B1 (0.46) | FDPSBTN3A1GGPS1PDE3ACYP11B1 | |
| SCHEMBL1029369 | 0.72 | FDPS (0.50) | FDPSBTN3A1LMNAGGPS1CA12 | |
| SCHEMBL1027186 | 0.72 | FDPS (0.50) | FDPSBTN3A1LMNAGGPS1CA12 | |
| SCHEMBL1083518 | 0.70 | FDPS (0.49) | FDPSBTN3A1LMNAGGPS1CA12 | |
| SCHEMBL2532821 | 0.70 | CYP11B1 (0.50) | FDPSBTN3A1GGPS1PDE3ACYP11B1 | |
| SCHEMBL1157059 | 0.69 | GGPS1 (0.47) | FDPSBTN3A1LMNAGGPS1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110257131-A1 | PHENYLALKYL-IMIDAZOLE-BISPHOSPHONATE COMPOUNDS | NOVARTIS AG (CH) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257131-A1 | PHENYLALKYL-IMIDAZOLE-BISPHOSPHONATE COMPOUNDS | PTEN, INPP5D, PPIP5K2 | FDPS 562/4885BTN3A1 3094/4885LMNA 3046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.